健保碼 | 新價 | 藥品名稱 | 製藥廠 |
AC58837277 | 12650 | PG2 LYO. INJECTION 500MG | 中國化學製藥股份有限公司新豐工 |
BC24071100 | 503 | VALCYTE FILM-COATED TABLETS 450MG | PATHEON, INC. |
BC24332421 | 69 | RELESTAT OPHTHALMIC SOLUTION 0.05% | ALLERGAN PHARMACEUTICALS IRELA |
BC25377414 | 303 | TAFLOTAN OPHTHALMIC SOLUTION | SANTEN PHARMACEUTICAL CO., LTD |
BC26578100 | 672 | Tafinlar Capsules 50mg | GLAXO OPERATIONS UK LIMITED |
BC26579100 | 908 | Tafinlar Capsules 75mg | GLAXO OPERATIONS UK LIMITED |
BC26615405 | 13.8 | TAFLOTAN-S OPHTHALMIC SOLUTION | SANTEN PHARMACEUTICAL CO. LTD. |
BC26714100 | 401 | Valgovir 450 F.C. Tablets | HETERO LABS LIMITED, UNIT V |
BC26770405 | 15.5 | TAPCOM-S OPHTHALMIC SOLUTION | LABORATOIRE UNITHER |
BC26817100 | 1010 | Mekinist Film-Coated Tablets 0.5mg | GLAXOSMITHKLINE MANUFACTURING |
BC26818100 | 3636 | Mekinist Film-Coated Tablets 2mg | GLAXOSMITHKLINE MANUFACTURING |
BC27087210 | 1792 | Zerbaxa for Injection | Steri-Pharma, LLC |
BC27592100 | 401 | VALGAN-450 [VALGANCICLOVIR TABLETS 450MG] | HETERO LABS LIMITED, UNIT V |
BC27596100 | 519 | Erleada Film-Coated Tablets 60mg | JANSSEN ORTHO LLC |
BC27801100 | 1600 | Talzenna Capsules 0.25 mg | EXCELLA GMBH & CO. KG |
BC27802100 | 6400 | Talzenna Capsules 1 mg | EXCELLA GMBH & CO. KG |
BC27856100 | 276 | Smyraf film-coated Tablets 50mg | ASTELLAS PHARMA TECH CO.,LTD. |
BC27857100 | 552 | Smyraf film-coated Tablets 100mg | ASTELLAS PHARMA TECH CO.,LTD. |
KC01113209 | 11226 | EMGALITY INJECTION | ELI LILLY AND COMPANY |
KC01129299 | 41.3 | Refixia powder and solvent for solution for injection 500 IU | NOVO NORDISK A/S |
KC01130299 | 41.3 | Refixia powder and solvent for solution for injection 1000 IU | NOVO NORDISK A/S |
KC01131299 | 41.3 | Refixia powder and solvent for solution for injection 2000 IU | NOVO NORDISK A/S |
VC00064100 | 1832 | MAYZENT 2MG FILM COATED TABLETS | NOVARTIS PHARMA STEIN AG |
VC00065100 | 303 | MAYZENT 0.25MG FILM COATED TABLETS | NOVARTIS PHARMA STEIN AG |